Brief: Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine for Treatment of Insomnia or Anxiety
22/11/2023 13:07
Nov 22 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES ANNOUNCES GRANT OF U.S. PATENT
COVERING
BLARCAMESINE (ANAVEX®2-73) FOR TREATMENT OF INSOMNIA OR ANXIETY
Source text for Eikon: ID:nGNX5M7sK0
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board